ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burgos, M.V.
Right arrow Articles by Pym, A.S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burgos, M.V.
Right arrow Articles by Pym, A.S.
Eur Respir J 2002; 20:54S-65S
Copyright ©ERS Journals Ltd 2002


Molecular epidemiology of tuberculosis

M.V. Burgos and A.S. Pym

Division of Infectious Diseases & Geographic Medicine, Dept of Medicine, Stanford University Medical Centre, Stanford, CA, USA

CORRESPONDENCE: M.V. Burgos, Division of Infectious Diseases & Geographic Medicine, Stanford University Medical Center, Room S-156, 300 Pasteur Drive, Stanford, CA, 94305-5107, USA. Fax: 1 6504987011. E-mail: marcos@molepi.stanford.edu

Keywords: drug resistance, fitness, genomics, molecular epidemiology, Mycobacterium tuberculosis, restriction fragment length polymorphism

Received: February 14, 2002
Accepted March 13, 2002

Despite the almost 50 yrs since the introduction of curative antituberculosis drugs, Mycobacterium tuberculosis continues to exert an enormous toll on world health, and tuberculosis remains the world's leading cause of death due to a single infectious agent. This has stimulated research efforts into finding new tools to tackle the continuing tuberculosis pandemic.

One of the few successes to date has been the development of a new discipline, molecular epidemiology. This has added a further dimension to the classical epidemiology of tuberculosis and enhanced understanding of how M. tuberculosis continues to be successfully transmitted within populations. In the process, inadequacies in tuberculosis control programmes have been identified, helping accumulate resources for their improvement.

Other technologies, based on knowledge of the complete genome sequence of M. tuberculosis, which will provide newer tools for probing the epidemiology of tuberculosis, are now emerging. In spite of these advances, tuberculosis continues to remain a devastating infectious disease, disproportionately impacting on the world's poorest countries.

The future challenge for molecular epidemiology is to provide better understanding of the transmission dynamics of tuberculosis in these settings and to stimulate the implementation of control measures on a more global scale.




This article has been cited by other articles:


Home page
Occup. Environ. Med.Home page
A Seidler, A Nienhaus, and R Diel
The transmission of tuberculosis in the light of new molecular biological approaches
Occup. Environ. Med., February 1, 2004; 61(2): 96 - 102.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the European Respiratory Society.